# Enicepatide (CT-388) phase 1: weight loss over 4 weeks

Source: https://pepvault.app/research/enicepatide-chakravarthy-2026

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Enicepatide](https://pepvault.app/research#enicepatide)

Randomized trial · people

# Enicepatide: -4.7% to -8.0% body weight change by day 29 in phase 1

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

This is an early human result for enicepatide: weight loss and better blood sugar over 4 weeks, with side effects similar to other drugs in its class.

- **Kind:** Randomized trial
- **Studied in:** People
- **Published:** 2026
- **Journal:** Mol Metab

## What they tested

The team wanted to know whether enicepatide (CT-388), a weekly shot that acts on both the GLP-1 and GIP receptors, improves weight loss and blood sugar control in people as it did in lab models.

## How the study was done

This was a phase 1, double-blind, randomized, placebo-controlled trial (placebo is a dummy shot) in otherwise healthy adults with overweight or obesity. Participants got either single shots under the skin (0.5-7.5 mg) or 4 weekly shots (5-12 mg). The paper also included cell tests and studies in mice and monkeys.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking enicepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

In people, mean body weight changed by -4.7% to -8.0% from the start to day 29 across the enicepatide doses, compared with -0.5% on placebo. Blood sugar measures improved both while fasting and during an oral glucose tolerance test, a test of how the body handles a sugary drink. Most side effects were mild or moderate, and the safety pattern matched other incretin-based medicines. In mice, the compound lowered body weight, reduced appetite and improved MASH pathology (MASH is a fatty liver disease with inflammation), and it improved blood sugar control in both mice and monkeys.

## What it doesn’t show

This was an early, short trial of about 4 weeks in otherwise healthy people, so it can't show longer-term weight loss or how the drug works in people with type 2 diabetes. The liver and appetite results came from mice, not people.

## The paper

Chakravarthy et al. Effects of CT-388, a once-weekly signaling-biased dual GLP-1/GIP receptor agonist, on weight loss and glycemic control in preclinical models and participants with obesity. Mol Metab. 2026.

- [PubMed (PMID 41319798)](https://pubmed.ncbi.nlm.nih.gov/41319798/)
- [The paper (DOI 10.1016/j.molmet.2025.102291)](https://doi.org/10.1016/j.molmet.2025.102291)
- [ClinicalTrials.gov (NCT04838405)](https://clinicaltrials.gov/study/NCT04838405)

## The compound

- [Enicepatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/enicepatide)
- [Enicepatide dose guide](https://pepvault.app/lab/dosage/enicepatide)

## With this study

### Enicepatide

- [Enicepatide: the full reference](https://pepvault.app/peptides/enicepatide)
- [Enicepatide dose guide](https://pepvault.app/lab/dosage/enicepatide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/enicepatide-10mg)

### Studies

- [The study on the research page](https://pepvault.app/research#enicepatide)

### Compared with

- [Tirzepatide vs Enicepatide](https://pepvault.app/peptides/compare/tirzepatide-vs-enicepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [GIP](https://pepvault.app/glossary/gip)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Incretin](https://pepvault.app/glossary/incretin)
- [MASH](https://pepvault.app/glossary/mash)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking enicepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking enicepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Enicepatide

- [Enicepatide: the full reference](https://pepvault.app/peptides/enicepatide)
- [Enicepatide dose guide](https://pepvault.app/lab/dosage/enicepatide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/enicepatide-10mg)

### Studies

- [The study on the research page](https://pepvault.app/research#enicepatide)

### Compared with

- [Tirzepatide vs Enicepatide](https://pepvault.app/peptides/compare/tirzepatide-vs-enicepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [GIP](https://pepvault.app/glossary/gip)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Incretin](https://pepvault.app/glossary/incretin)
- [MASH](https://pepvault.app/glossary/mash)

<!--promo-->

PepVault for iPhone

## Taking enicepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Enicepatide](https://pepvault.app/research#enicepatide)

## The library

- [Enicepatide](https://pepvault.app/peptides/enicepatide)
- [Enicepatide dose guide](https://pepvault.app/lab/dosage/enicepatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
